COMPOSITION:
Each film-coated LuciFine tablet contains: finerenone 10mg
INDICATION:
LuciFine is a non-steroidal mineralocorticoid receptor antagonist (MRA) indicated to reduce the risk of sustained eGFR decline, end stage kidney disease, cardiovascular death, non-fatal myocardial infarction, and hospitalization for heart failure in adult patients with chronic kidney disease (CKD) associated with type 2 diabetes (T2D).
DOSAGE AND USE:
· The recommended starting dosage is 10 mg or 20 mg orally once daily based on estimated glomerular filtration rate (eGFR) and serum potassium thresholds.
· Increase dosage after 4 weeks to the target dose of 20 mg once daily, based on eGFR and serum potassium thresholds.
Tablets should be swallowed whole & not chewed or crushed.
STORAGE:
in a dry place and store at 20°C to 25°C.
MANUFACTURED AND MARKETED BY:
LUCIUS PHARMACEUTICALS(LAO) CO., LTD
No.26, Thongmang village, Xaythany district, Vientiane Capital, Laos
WARNING:
Keep medicine out of the reach of Children.
Do not administered LuciFine in Pregnancy and Lactation patient treatment.
Customer Reviews
Write a review
Cobus Bester
Cobus Bester on Mar 03, 2023
Can’t wait to start mixin’ with this one! Irba-irr-Up-up-up-up-date your theme!
Report as Inappropriate